FDA Approved: QUILLICHEW ER — Supplemental Application (NextWave Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved a supplemental application for Quillichew ER (methylphenidate hydrochloride) submitted by NextWave Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE)